FDA Approved: LIOMNY — Supplemental Application (SIGMAPHARM LABORATORIES, LLC)

View source ↗

Summary

FDA approved a supplemental application for LIOMNY (liothyronine sodium) submitted by SigmaPharm Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism

Drugs mentioned

• LIOMNY (LIOTHYRONINE SODIUM)

Snippet

SUPPL AP for LIOMNY (LIOTHYRONINE SODIUM)